Extended release tablet of clarithromycin

Open in the gastro-intestinal tract environment sustained-release pharmaceutical composition for erythromycin derivatives. The composition for polymer containing erythromycin derivatives and pharmaceutical care affordable, therefore, when oral, compared with the quick release composition for erythromycin derivatives, the combination producing statistically significantly lower in the plasma Cmax, when multi-dosing at the same time, remained basically the same quick release composition for erythromycin derivatives of bioavailability and minimum concentration. Compared with the quick release combo, combination invention improves the sense of taste and reduce gastrointestinal side effects.